NanoString analysis of a rat liver mRNA panel following TCDD treatment

ABSTRACT: Profiling of mRNA abundances with high-throughput platforms such as microarrays and RNA-Seq has become an important tool in both basic and biomedical research. However these platforms remain prone to systematic errors, and have challenges in clinical and industrial application. As a result it is standard practice to validate a subset of key results using alternate technologies. Similarly, clinical and industrial applications typically involve transitions from high-throughput discovery platform to medium-throughput validation ones. These medium-throughput validation platforms have high technical reproducibility and reduced sample input needs, and low sensitivity to sample-quality (e.g. for processing FFPE specimens). Unfortunately, while medium-throughput platforms have proliferated, there

ORGANISM(S): Rattus norvegicus

SUBMITTER: Stephenie Prokopec 

PROVIDER: E-GEOD-43251 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress